Terms: = Kidney tumors AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Prognosis
121 results:
1. Exosomal long non-coding RNA MALAT1: a candidate of liquid biopsy in monitoring of Wilms' tumor.
Sharma D; Singh A; Wilson C; Swaroop P; Kumar S; Yadav DK; Jain V; Agarwala S; Husain M; Sharawat SK
Pediatr Surg Int; 2024 Feb; 40(1):57. PubMed ID: 38353772
[TBL] [Abstract] [Full Text] [Related]
2. Integrated single-cell and bulk characterization of branched chain amino acid metabolism-related key gene BCAT1 and association with prognosis and immunogenicity of clear cell renal cell carcinoma.
Zheng J; Liu Y; Wang J; Shi J; Li L; Jiang X; Tao L
Aging (Albany NY); 2024 Feb; 16(3):2715-2735. PubMed ID: 38309289
[TBL] [Abstract] [Full Text] [Related]
3. Identification of an immune-related eRNA prognostic signature for clear cell renal cell carcinoma.
Lv Y; Niu L; Li Q; Shao W; Yan X; Li Y; Yue Y; Chen H
Aging (Albany NY); 2024 Jan; 16(3):2232-2248. PubMed ID: 38289619
[TBL] [Abstract] [Full Text] [Related]
4. Hsa_circ_0086414/transducer of ERBB2 (TOB2) axis-driven lipid elimination and tumor suppression in clear cell renal cell cancer via perilipin 3.
Meng X; Li W; Yu T; Lu F; Wang C; Yuan H; Yang W; Dong W; Xiao W; Zhang X
Int J Biol Macromol; 2024 Mar; 261(Pt 1):129636. PubMed ID: 38272402
[TBL] [Abstract] [Full Text] [Related]
5. Identification and validation of prognostic and tumor microenvironment characteristics of necroptosis index and BIRC3 in clear cell renal cell carcinoma.
Wei K; Zhang X; Yang D
PeerJ; 2023; 11():e16643. PubMed ID: 38130918
[TBL] [Abstract] [Full Text] [Related]
6. Identification of Crotonylation Metabolism Signature Predicting Overall Survival for Clear Cell Renal Cell Carcinoma.
Zheng J; Liu Y; Wei K; Shi J; Li L; Jiang X; Tao L
Int J Clin Pract; 2023; 2023():5558034. PubMed ID: 38058677
[TBL] [Abstract] [Full Text] [Related]
7. [Mechanism of nuclear protein 1 in the resistance to axitinib in clear cell renal cell carcinoma].
Liu YC; Wu ZL; Ge LY; DU T; Wu YQ; Song YM; Liu C; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 55(5):781-792. PubMed ID: 37807730
[TBL] [Abstract] [Full Text] [Related]
8. TIMP1 shapes an immunosuppressive microenvironment by regulating anoikis to promote the progression of clear cell renal cell carcinoma.
Li Q; Wei K; Zhang X; Lv Y; Li M; Zhou C; Su S; Hou D; Hou J
Aging (Albany NY); 2023 Sep; 15(17):8908-8929. PubMed ID: 37688768
[TBL] [Abstract] [Full Text] [Related]
9. HMGCS2 serves as a potential biomarker for inhibition of renal clear cell carcinoma growth.
Mao H; Wang R; Shao F; Zhao M; Tian D; Xia H; Zhao Y
Sci Rep; 2023 Sep; 13(1):14629. PubMed ID: 37670031
[TBL] [Abstract] [Full Text] [Related]
10. Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma.
Jiang S; Dong Y; Wang J; Zhang X; Liu W; Wei Y; Zhou H; Shen L; Yang J; Zhu Q
Front Immunol; 2023; 14():1207061. PubMed ID: 37662929
[TBL] [Abstract] [Full Text] [Related]
11. Sphingosine kinase 1 regulates lipid metabolism to promote progression of kidney renal clear cell carcinoma.
Zhao L; Wang Z; Xu Y; Zhang P; Qiu J; Nie D; Wu G; Chen C; Chang Y; Xia Q
Pathol Res Pract; 2023 Aug; 248():154641. PubMed ID: 37467634
[TBL] [Abstract] [Full Text] [Related]
12. GPD1L inhibits renal cell carcinoma progression by regulating PINK1/Parkin-mediated mitophagy.
Liu T; Zhu H; Ge M; Pan Z; Zeng Y; Leng Y; Yang K; Cheng F
J Cell Mol Med; 2023 Aug; 27(16):2328-2339. PubMed ID: 37382962
[TBL] [Abstract] [Full Text] [Related]
13. LINC01480 as a Prognostic Biomarker Associated With Proliferation, Migration, and Invasion of Clear Cell Renal Cell Carcinoma.
Ma Y; Wu C; Deng S
Anticancer Res; 2023 Jul; 43(7):3037-3046. PubMed ID: 37351956
[TBL] [Abstract] [Full Text] [Related]
14. Long noncoding RNA UFC1 acts as an oncogene via stimulating EZH2-induced inhibition of APC expression in renal cell carcinoma.
Wang J; Liu G
Cell Mol Biol (Noisy-le-grand); 2023 Apr; 69(4):152-156. PubMed ID: 37329532
[TBL] [Abstract] [Full Text] [Related]
15. Upregulated PPP1R14B is connected to cancer progression and immune infiltration in kidney renal clear cell carcinoma.
Cheng L; Mi J; Zhang J; Huang H; Mo Z
Clin Transl Oncol; 2024 Jan; 26(1):119-135. PubMed ID: 37261660
[TBL] [Abstract] [Full Text] [Related]
16. ADAM metallopeptidase with thrombospondin type 1 motif 16 is a potential marker for prognosis in clear cell renal cell carcinoma.
Bai C; Chen DG
Pathol Int; 2023 Jul; 73(7):297-305. PubMed ID: 37132990
[TBL] [Abstract] [Full Text] [Related]
17. Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation: Clinicopathologic Correlation and Molecular Findings.
Gama A; Xu H; Yang XJ; Choy B
Int J Surg Pathol; 2024 Feb; 32(1):11-16. PubMed ID: 37063043
[No Abstract] [Full Text] [Related]
18. Histone demethylase KDM4B contributes to advanced clear cell renal carcinoma and association with copy number variations and cell cycle progression.
Tang H; Guan Y; Yuan Z; Guo T; Tan X; Fan Y; Zhang E; Wang X
Epigenetics; 2023 Dec; 18(1):2192319. PubMed ID: 36952476
[TBL] [Abstract] [Full Text] [Related]
19. ENO2 affects the EMT process of renal cell carcinoma and participates in the regulation of the immune microenvironment.
Chen WJ; Yang W; Gong M; He Y; Xu D; Chen JX; Chen WJ; Li WY; Wang YQ; Dong KQ; Song X; Pan XW; Cui XG
Oncol Rep; 2023 Feb; 49(2):. PubMed ID: 36562383
[TBL] [Abstract] [Full Text] [Related]
20. KLK4 Silencing Inhibits the Growth of Chromophobe Renal Cell Carcinoma through ERK/AKT Signaling Pathway.
Fan B; Niu Y; Zhang A; Wei S; Ma Y; Su J; Ren Z
Kidney Blood Press Res; 2022; 47(12):702-710. PubMed ID: 36260980
[TBL] [Abstract] [Full Text] [Related]
[Next]
